Validity and Reliability of the Turkish Version of the 4-Item Short Form of the Pain Anxiety Symptom Scale

April 17, 2026 updated by: Atahan TURHAN, Kirsehir Ahi Evran Universitesi

Validity and Reliability of the Turkish Version of the 4-Item Short Form of the PASS

The primary aim of the study was to determine the reliability and validity of the Turkish version of the 4-Item Short Form of the Pain Anxiety Symptom Scale. The secondary aim of the study was to determine the level of pain-related anxiety in individuals with chronic pain.

Study Overview

Status

Enrolling by invitation

Conditions

Study Type

Observational

Enrollment (Estimated)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Merkez
      • Kırşehir, Merkez, Turkey (Türkiye), 40100
        • Kirsehir Ahi Evran University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The study will be implemented at the Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center between the dates after receiving the ethics committee approval. Patients who apply to the Physical Medicine and Rehabilitation Polyclinic with complaints of pain will be examined by a physical therapist. Patients who are diagnosed with chronic pain through physical examination, meet the inclusion criteria and agree to participate in the study will be included in the study.

Description

Inclusion Criteria:

  1. Between the ages of 18-65
  2. Having pain 4 or more days a week
  3. Having weekly pain intensity of 3 or more according to the Numeric Pain Rating Scale
  4. Having chronic pain lasting at least 3 months
  5. Being able to read and write and having no cognitive problems
  6. Individuals who volunteer to participate in the study will be included.

Exclusion Criteria:

1. Having pain limited to headache only

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Study Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pain Anxiety Symptom Scale 4-Item Short Form
Time Frame: 20 weeks
20 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Visual Analog Scale
Time Frame: 20 weeks
20 weeks
Chronic Pain Admission Form
Time Frame: 20 weeks
20 weeks
Beck Anxiety Inventory
Time Frame: 20 weeks
20 weeks
Chronic Pain Acceptance Questionnaire
Time Frame: 20 weeks
20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kirsehir Ahi Evran Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2025

Primary Completion (Estimated)

June 13, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

January 6, 2025

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEU-T.ATAHAN-009

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scale Reliability Validity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe